基因ID | taxid | GeneDate LocusTag | Symbol Synonyms | Symbolfna Fullnamefna | dbXrefs | chromosome maplocation | description | genetype fnastatus | Otherdesignations | Featuretype |
112202 | 10090 | 20170408 | Skts9 | Skts9 skin tumor susceptibility 9 | MGI:MGI:1351489 | 16 16 13.8 cM | skin tumor susceptibility 9 | unknown O | ||
112203 | 10090 | 20170408 | Afpq6 | Afpq6 abdominal fat percent QTL 6 | MGI:MGI:1889212 | 17 | abdominal fat percent QTL 6 | unknown O | ||
112204 | 10090 | 20170408 | Afw10 | Afw10 abdominal fat weight QTL 10 | MGI:MGI:1890483 | 12 | abdominal fat weight QTL 10 | unknown O | ||
112205 | 10090 | 20170408 | Ity2 | Ity2 immunity to S. typhimurium 2 | MGI:MGI:1891849 | 11 11 105.28 cM | immunity to S. typhimurium 2 | unknown O | ||
112206 | 10090 | 20170408 | Remslp3 | Remslp3 rapid eye movement sleep 3 | MGI:MGI:2137674 | 16 16 36.36 cM | rapid eye movement sleep 3 | unknown O | ||
112207 | 10090 | 20170408 | Scc9 | Scc9 colon tumor susceptibility 9 | MGI:MGI:1347110 | 10 10 64.71 cM | colon tumor susceptibility 9 | unknown O | ||
112208 | 10090 | 20190101 | Ity3 | Ity3 immunity to S. typhimurium 3 | MGI:MGI:1891848 | 1 1 56.92 cM | immunity to S. typhimurium 3 | unknown O | ||
112209 | 10090 | 20170408 | Rapop2 | Rapop2 radiation-induced apoptosis 2 | MGI:MGI:104989 | 9 | radiation-induced apoptosis 2 | unknown O | ||
112210 | 10090 | 20170408 | Tlsm1 | Tlsm1 thymic lymphoma susceptible 1 | MGI:MGI:105954 | 7 7 81.27 cM | thymic lymphoma susceptible 1 | unknown O | ||
112211 | 10090 | 20190402 | Daq14 | Daq14 directional asymmetry QTL 14 | MGI:MGI:1098247 | 15 15 30.86 cM | directional asymmetry QTL 14 | unknown O | ||
112212 | 10090 | 20190402 | Daq15 | Daq15 directional asymmetry QTL 15 | MGI:MGI:1098248 | 15 | directional asymmetry QTL 15 | unknown O | ||
112213 | 10090 | 20190402 | Daq16 | Daq16 directional asymmetry QTL 16 | MGI:MGI:1098249 | 18 | directional asymmetry QTL 16 | unknown O | ||
112214 | 10090 | 20190402 | Daq10 | Daq10 directional asymmetry QTL 10 | MGI:MGI:1098250 | 13 | directional asymmetry QTL 10 | unknown O | ||
112215 | 10090 | 20190402 | Daq11 | Daq11 directional asymmetry QTL 11 | MGI:MGI:1098251 | 13 | directional asymmetry QTL 11 | unknown O | ||
112216 | 10090 | 20190402 | Daq12 | Daq12 directional asymmetry QTL 12 | MGI:MGI:1098252 | 15 15 16.74 cM | directional asymmetry QTL 12 | unknown O | ||
112217 | 10090 | 20190402 | Daq13 | Daq13 directional asymmetry QTL 13 | MGI:MGI:1098253 | 15 15 16.74 cM | directional asymmetry QTL 13 | unknown O | ||
112218 | 10090 | 20190402 | Faq10 | Faq10 fluctuating asymmetry QTL 10 | MGI:MGI:1098277 | 19 19 13.82 cM | fluctuating asymmetry QTL 10 | unknown O | ||
112219 | 10090 | 20190402 | Faq11 | Faq11 fluctuating asymmetry QTL 11 | MGI:MGI:1098278 | 19 19 51.45 cM | fluctuating asymmetry QTL 11 | unknown O | ||
112220 | 10090 | 20170408 | Wt10q2 | Wt10q2 body weight, 10 weeks, QTL 2 | MGI:MGI:1344339 | 3 | body weight, 10 weeks, QTL 2 | unknown O | ||
112221 | 10090 | 20170408 | Wt10q1 | Wt10q1 body weight, 10 weeks, QTL 1 | MGI:MGI:1344340 | 1 | body weight, 10 weeks, QTL 1 | unknown O | ||
112222 | 10090 | 20170408 | Skts12 | Skts12 skin tumor susceptibility 12 | MGI:MGI:1351470 | 6 6 77.7 cM | skin tumor susceptibility 12 | unknown O | ||
112223 | 10090 | 20170408 | Skts11 | Skts11 skin tumor susceptibility 11 | MGI:MGI:1351483 | 6 6 37.96 cM | skin tumor susceptibility 11 | unknown O | ||
112224 | 10090 | 20170408 | Rapop3 | Rapop3 radiation-induced apoptosis 3 | MGI:MGI:104994 | 3 3 34.38 cM | radiation-induced apoptosis 3 | unknown O | ||
112225 | 10090 | 20170408 | Wt10q3 | Wt10q3 body weight, 10 weeks, QTL 3 | MGI:MGI:1344409 | 11 | body weight, 10 weeks, QTL 3 | unknown O | ||
112226 | 10090 | 20170408 | Skts10 | Skts10 skin tumor susceptibility 10 | MGI:MGI:1351482 | 17 | skin tumor susceptibility 10 | unknown O | ||
112227 | 10090 | 20170408 | Afpq10 | Afpq10 abdominal fat percent QTL 10 | MGI:MGI:1889210 | 12 | abdominal fat percent QTL 10 | unknown O | ||
112228 | 10090 | 20170408 | Bts2 | Bts2 bladder tumor susceptibility 2 | MGI:MGI:1934674 | 6 6 12.36 cM | bladder tumor susceptibility 2 | unknown O | ||
112229 | 10090 | 20211002 | Psl1 Tpa | Psl1 promotion susceptibility QTL 1 | MGI:MGI:1345637 | 9 9 57.46 cM | promotion susceptibility QTL 1 | unknown O | ||
112230 | 10090 | 20170408 | Pbw1 | Pbw1 pentobarbital withdrawal QTL 1 | MGI:MGI:1345638 | 1 1 80.33 cM | pentobarbital withdrawal QTL 1 | unknown O | ||
112231 | 10090 | 20170408 | Pid2 | Pid2 prion incubation determinant 2 | MGI:MGI:1890506 | 9 9 20.74 cM | prion incubation determinant 2 | unknown O | ||
112232 | 10090 | 20170408 | Bts1 | Bts1 bladder tumor susceptibility 1 | MGI:MGI:1890966 | 2 2 73.8 cM | bladder tumor susceptibility 1 | unknown O | ||
112233 | 10090 | 20170408 | Bhr1 | Bhr1 bronchial hyperresponsiveness 1 | MGI:MGI:104739 | 2 | bronchial hyperresponsiveness 1 | unknown O | ||
112235 | 10090 | 20220515 | Par3 | Par3 pulmonary adenoma resistance 3 | MGI:MGI:1101767 | 12 12 37.16 cM | pulmonary adenoma resistance 3 | unknown O | ||
112236 | 10090 | 20170408 | Gct2 | Gct2 granulosa cell tumorigenesis 2 | MGI:MGI:1330296 | 12 12 21.09 cM | granulosa cell tumorigenesis 2 | unknown O | ||
112237 | 10090 | 20170408 | Gct3 | Gct3 granulosa cell tumorigenesis 3 | MGI:MGI:1330297 | 15 15 29.03 cM | granulosa cell tumorigenesis 3 | unknown O | ||
112238 | 10090 | 20170408 | Pid3 | Pid3 prion incubation determinant 3 | MGI:MGI:1890507 | 11 11 37.96 cM | prion incubation determinant 3 | unknown O | ||
112239 | 10090 | 20170408 | Rapop5 | Rapop5 radiation-induced apoptosis 5 | MGI:MGI:1890917 | 15 15 19.26 cM | radiation-induced apoptosis 5 | unknown O | ||
112240 | 10090 | 20170408 | Bhr3 | Bhr3 bronchial hyperresponsiveness 3 | MGI:MGI:104733 | 17 17 2.11 cM | bronchial hyperresponsiveness 3 | unknown O | ||
112241 | 10090 | 20170408 | Bhr2 | Bhr2 bronchial hyperresponsiveness 2 | MGI:MGI:104734 | 15 15 29.03 cM | bronchial hyperresponsiveness 2 | unknown O | ||
112242 | 10090 | 20170408 | Bhr4 | Bhr4 bronchial hyperresponsiveness 4 | MGI:MGI:108492 | 13 | bronchial hyperresponsiveness 4 | unknown O | ||
112243 | 10090 | 20170408 | Sluc7 | Sluc7 susceptibility to lung cancer 7 | MGI:MGI:1335097 | 6 6 11.91 cM | susceptibility to lung cancer 7 | unknown O | ||
112244 | 10090 | 20170408 | Aod2 | Aod2 autoimmune ovarian dysgenesis 2 | MGI:MGI:1341104 | 3 3 18.3 cM | autoimmune ovarian dysgenesis 2 | unknown O | ||
112246 | 10090 | 20170408 | Sluc9 | Sluc9 susceptibility to lung cancer 9 | MGI:MGI:1335080 | 8 8 62.82 cM | susceptibility to lung cancer 9 | unknown O | ||
112247 | 10090 | 20170408 | Sluc8 | Sluc8 susceptibility to lung cancer 8 | MGI:MGI:1335081 | 7 7 88.86 cM | susceptibility to lung cancer 8 | unknown O | ||
112248 | 10090 | 20170408 | Sluc5 | Sluc5 susceptibility to lung cancer 5 | MGI:MGI:1335083 | 1 1 76.25 cM | susceptibility to lung cancer 5 | unknown O | ||
112249 | 10090 | 20170408 | Sluc6 | Sluc6 susceptibility to lung cancer 6 | MGI:MGI:1335085 | 4 4 70.02 cM | susceptibility to lung cancer 6 | unknown O | ||
112250 | 10090 | 20170408 | Smgd1 | Smgd1 submucosal gland distribution 1 | MGI:MGI:2136868 | 9 9 51.41 cM | submucosal gland distribution 1 | unknown O | ||
112251 | 10090 | 20170408 | Orch5 | Orch5 autoimmune orchitis resistance 5 | MGI:MGI:108002 | 1 | autoimmune orchitis resistance 5 | unknown O | ||
112252 | 10090 | 20170408 | Cia2 | Cia2 collagen induced arthritis QTL 2 | MGI:MGI:1333775 | 2 2 34.9 cM | collagen induced arthritis QTL 2 | unknown O | ||
112253 | 10090 | 20170408 | Cia3 | Cia3 collagen induced arthritis QTL 3 | MGI:MGI:1333814 | 6 6 52.75 cM | collagen induced arthritis QTL 3 | unknown O |
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024 |